NAS
TEVA icon

Nykredit A/S’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Nykredit A/S’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Buy
+340,196
New +$11.3M 0.04% 309

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nykredit A/S's TEVA Position: Q2 2026 in Review

Nykredit A/S opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 340,196 shares worth $11.5M. The stake represents 0.04% of the portfolio and ranks #309 among its holdings.

676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Nykredit A/S held 340,196 shares of Teva Pharmaceutical Industries Limited worth $11.5M as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Nykredit A/S position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.04% of Nykredit A/S's portfolio in Q2 2026, its #309 holding.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.